Storey, Claire L.
,
Hanna, Gerard G.
Greystoke, Alastair
Article History
First Online: 8 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: G.G.H. has received speaker fees from AstraZeneca UKMC, Roche Holding AG, Novartis International AG, consulting fees from Pfizer Inc. and has grant support under negotiation with the CTC committee of Cancer Research UK. A.G. has received speaker fees from AstraZeneca, Pfizer, MSD, Boehringer Ingelheim, Novartis and BMS, has received grant support from the Cancer Research UK Centre at the Northern Institute for Cancer Research and has attended advisory boards for AstraZeneca UKMC. C.L.S. has no conflicts of interest. The authors do not report any conflict of interest with regard to the contents of this study other than those stated.
: This promotional supplement has been commissioned and funded by AstraZeneca UK Limited ('AstraZeneca').